Table of Contents Author Guidelines Submit a Manuscript
Journal of Obesity
Volume 2011, Article ID 210484, 8 pages
http://dx.doi.org/10.1155/2011/210484
Research Article

Assessment of Acute and Chronic Pharmacological Effects on Energy Expenditure and Macronutrient Oxidation in Humans: Responses to Ephedrine

1Clinical Unit in Cambridge, GlaxoSmithKline, ACCI, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge CB2 2QQ, UK
2Wellcome Trust Clinical Research Facility, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 2QQ, UK
3Metabolic Pathways Center of Excellence for Drug Discovery, GlaxoSmithKline Research Triangle Park, NC 27709, USA

Received 17 May 2010; Accepted 6 July 2010

Academic Editor: L. Van Gaal

Copyright © 2011 Antonella Napolitano et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [5 citations]

The following is the list of published articles that have cited the current article.

  • Zhijie Zheng, Tongmeng Yan, Weiying Chen, Ling Ye, and Lan Tang, “Pharmacokinetic determination of ephedrine in Herba Ephedrae and Wu Tou Tan g decoctions in rats using ultra performance liquid chromatography tandem m ass spectrometry,” Xenobiotica, vol. 42, no. 8, pp. 775–783, 2012. View at Publisher · View at Google Scholar
  • A. L. Carey, M. F. Formosa, B. Every, D. Bertovic, N. Eikelis, G. W. Lambert, V. Kalff, S. J. Duffy, M. H. Cherk, and B. A. Kingwell, “Ephedrine activates brown adipose tissue in lean but not obese humans,” Diabetologia, vol. 56, no. 1, pp. 147–155, 2012. View at Publisher · View at Google Scholar
  • Marietta Charakida, and Nicholas Finer, “Drug Treatment of Obesity in Cardiovascular Disease,” American Journal Of Cardiovascular Drugs, vol. 12, no. 2, pp. 93–104, 2012. View at Publisher · View at Google Scholar
  • Liang Chen, Yuan Bai, and YongWen Qin, “Research advances in drug treatment of obesity patients with cardiovascular diseases,” Pharmaceutical Care and Research, vol. 13, no. 2, pp. 81–84, 2013. View at Publisher · View at Google Scholar
  • Donald Schumacher, “Pharmacological Management of the Obese Patient,” American Journal of Lifestyle Medicine, vol. 9, no. 2, pp. 137–156, 2015. View at Publisher · View at Google Scholar